Hemolytic Disease of the Fetus and Newborn (HDFN): What Pediatric Providers Need to Know When Managing Hemolytic Disease in Newborns (HDN)

Discover new HDFN epidemiologic evidence, pathophysiology, and current and evolving management strategies that may impact your clinical practice.

Live Meeting
1.50 available credits
Information
October 10, 2022
06:30 PM - 08:30 PM PDT
Hilton Anaheim - Pacific Ballroom A
777 W Convention Way, Anaheim, CA 92802, United States
ReachMD Healthcare Image
Choose a format
Details
Presenters
Related
Comments
  • Overview

    What are the essential steps in managing hemolytic disease of the fetus and newborn (HDFN)? How soon after “the cord has been cut” does newborn care transfer from the maternal-fetal medicine specialist and ob-gyn to the pediatric team? This satellite symposium will help you better understand how care for neonates with hemolytic disease has evolved and provide you with the latest recommendations for timely evaluation and treatment—plus insights on how these might change the way you practice!

  • Program Schedule*

    Program Schedule

    Hilton Anaheim | Pacific Ballroom A | Anaheim, CA

    Monday, October 10, 2022, 6:30PM – 8:30PM PT

    6:30 pm–7:00 pm

    Registration and Dinner Social

    7:00 pm–7:10 pm

    Welcome, Introductions, Program Overview, Pretest

    Kara B. Markham, MD

    7:10 pm–7:15 pm

    Patient Perspective: Setting the Stage
    Bethany Weathersby, MS

    7:15 pm–7:25 pm

    Pathophysiology from the MFM Perspective:  Underlying Alloimmune Disorders of the Fetus/Newborn, Including HDFN and HDN Management

    Kara B. Markham, MD

    7:25 pm–7:35 pm

    The Role of the Neonatal Fc Receptor Pathway as a Therapeutic Means to Address HDFN and Other Fetal/Neonatal Alloimmune Disorders

    Kara B. Markham, MD

    7:35 pm–7:55 pm

    Pathophysiology from the Pediatric Perspective: Marrow Suppression, NICU Management

    James B. Bussel, MD

    7:55 pm–8:10 pm

    Patient Perspective: The Psychological and Social Impact of Maternal Alloimmunization and HDFN on Women Experiencing These Disorders and Their Families (Advocacy/Allo Hope Foundation’s Resources)

    Bethany Weathersby, MS

    8:10 pm–8:20 pm

    8:20 PM–8:30 PM

    *Subject to change

    Q&A

    Faculty

    Posttest and Closing Remarks

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Kara B. Markham, MD
    Associate Professor of Clinical Obstetrics & Gynecology
    University of Cincinnati
    Cincinnati, OH

    Bethany Weathersby, MS
    Chief Executive Officer
    Allo Hope Foundation
    Tuscaloosa, AL

    James B. Bussel, MD
    Professor Emeritus of Pediatrics
    Division of Hematology/Oncology,
    Department of Pediatrics
    Weill Cornell Medicine
    New York, NY

    Faculty disclosures are coming soon.

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Jay Runyon has nothing to disclose.
    • Robert Schneider, MSW, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Explain the pathophysiology underlying fetal/newborn alloimmune disorders, with a focus on HDN
    • Identify current diagnostic and treatment regimens for managing the physiologic consequences of HDF and HDN
    • Explain the role of the neonatal Fc receptor pathway as a therapeutic means to address HDFN
  • Target Audience

    This activity is designed to meet the educational needs of neonatologists, pediatricians, pediatric NPs, PAs, and nurses.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 1.5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should claim only the credit commensurate with the extent of their participation in the activity. 

  • Provider(s)/Educational Partner(s)

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.

  • Commercial Support

    This activity is supported by an independent educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

    This symposium is not sponsored, endorsed or accredited by the American Academy of Pediatrics.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Kate Nagele prior to the live event at knagele@glc.healthcare.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Details
Presenters
Related
Comments
  • Overview

    What are the essential steps in managing hemolytic disease of the fetus and newborn (HDFN)? How soon after “the cord has been cut” does newborn care transfer from the maternal-fetal medicine specialist and ob-gyn to the pediatric team? This satellite symposium will help you better understand how care for neonates with hemolytic disease has evolved and provide you with the latest recommendations for timely evaluation and treatment—plus insights on how these might change the way you practice!

  • Program Schedule*

    Program Schedule

    Hilton Anaheim | Pacific Ballroom A | Anaheim, CA

    Monday, October 10, 2022, 6:30PM – 8:30PM PT

    6:30 pm–7:00 pm

    Registration and Dinner Social

    7:00 pm–7:10 pm

    Welcome, Introductions, Program Overview, Pretest

    Kara B. Markham, MD

    7:10 pm–7:15 pm

    Patient Perspective: Setting the Stage
    Bethany Weathersby, MS

    7:15 pm–7:25 pm

    Pathophysiology from the MFM Perspective:  Underlying Alloimmune Disorders of the Fetus/Newborn, Including HDFN and HDN Management

    Kara B. Markham, MD

    7:25 pm–7:35 pm

    The Role of the Neonatal Fc Receptor Pathway as a Therapeutic Means to Address HDFN and Other Fetal/Neonatal Alloimmune Disorders

    Kara B. Markham, MD

    7:35 pm–7:55 pm

    Pathophysiology from the Pediatric Perspective: Marrow Suppression, NICU Management

    James B. Bussel, MD

    7:55 pm–8:10 pm

    Patient Perspective: The Psychological and Social Impact of Maternal Alloimmunization and HDFN on Women Experiencing These Disorders and Their Families (Advocacy/Allo Hope Foundation’s Resources)

    Bethany Weathersby, MS

    8:10 pm–8:20 pm

    8:20 PM–8:30 PM

    *Subject to change

    Q&A

    Faculty

    Posttest and Closing Remarks

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Kara B. Markham, MD
    Associate Professor of Clinical Obstetrics & Gynecology
    University of Cincinnati
    Cincinnati, OH

    Bethany Weathersby, MS
    Chief Executive Officer
    Allo Hope Foundation
    Tuscaloosa, AL

    James B. Bussel, MD
    Professor Emeritus of Pediatrics
    Division of Hematology/Oncology,
    Department of Pediatrics
    Weill Cornell Medicine
    New York, NY

    Faculty disclosures are coming soon.

    Reviewers/Content Planners/Authors:

    • Cindy Davidson has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Jay Runyon has nothing to disclose.
    • Robert Schneider, MSW, has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Explain the pathophysiology underlying fetal/newborn alloimmune disorders, with a focus on HDN
    • Identify current diagnostic and treatment regimens for managing the physiologic consequences of HDF and HDN
    • Explain the role of the neonatal Fc receptor pathway as a therapeutic means to address HDFN
  • Target Audience

    This activity is designed to meet the educational needs of neonatologists, pediatricians, pediatric NPs, PAs, and nurses.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 1.5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should claim only the credit commensurate with the extent of their participation in the activity. 

  • Provider(s)/Educational Partner(s)

    Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.

  • Commercial Support

    This activity is supported by an independent educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

    This symposium is not sponsored, endorsed or accredited by the American Academy of Pediatrics.

  • ADA Statement

    Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Kate Nagele prior to the live event at knagele@glc.healthcare.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments

Register

We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free